These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 3260283)
41. Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravis. Cardona A; Garchon HJ; Vernet-der-Garabedian B; Morel E; Gajdos P; Bach JF J Neuroimmunol; 1994 Aug; 53(1):9-16. PubMed ID: 8051300 [TBL] [Abstract][Full Text] [Related]
42. Acetylcholine receptor epitope in proteins of myasthenia gravis-associated thymomas and non-thymic tissues. Marx A; O'Connor R; Tzartos S; Kalies I; Kirchner T; Müller-Hermelink HK Thymus; 1989; 14(1-3):171-8. PubMed ID: 2482999 [TBL] [Abstract][Full Text] [Related]
43. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Schluep M; Willcox N; Vincent A; Dhoot GK; Newsom-Davis J Ann Neurol; 1987 Aug; 22(2):212-22. PubMed ID: 3662452 [TBL] [Abstract][Full Text] [Related]
44. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries. Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546 [TBL] [Abstract][Full Text] [Related]
52. Myasthenia gravis: remission not induced by blocking anti-idiotype antibodies. Heininger K; Hendricks M; Toyka KV; Kolb H Muscle Nerve; 1983 Jun; 6(5):386-7. PubMed ID: 6888417 [No Abstract] [Full Text] [Related]
53. Future therapeutic strategies in autoimmune myasthenia gravis. Psaridi-Linardaki L; Mamalaki A; Tzartos SJ Ann N Y Acad Sci; 2003 Sep; 998():539-48. PubMed ID: 14592926 [TBL] [Abstract][Full Text] [Related]
54. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens. Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261 [TBL] [Abstract][Full Text] [Related]
55. Disorders affecting the acetylcholine receptor: myasthenia gravis and congenital myasthenia. Vincent A J Recept Res; 1987; 7(1-4):599-616. PubMed ID: 2442386 [TBL] [Abstract][Full Text] [Related]
56. Anti-acetylcholine receptor antibody specificities in serum and in thymic cell culture supernatants from myasthenia gravis patients. Heidenreich F; Vincent A; Willcox N; Newsom-Davis J Neurology; 1988 Nov; 38(11):1784-8. PubMed ID: 3185915 [TBL] [Abstract][Full Text] [Related]
57. The auto-anti-idiotypic route to antireceptor antibodies. Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Wan KK; Sarangarajan R; Penn AS Ann N Y Acad Sci; 1986; 475():219-26. PubMed ID: 3491562 [No Abstract] [Full Text] [Related]
58. Suppression of antibody responses to the acetylcholine receptor by natural antibodies. Sundblad A; Hauser S; Holmberg D; Cazenave PA; Coutinho A Eur J Immunol; 1989 Aug; 19(8):1425-30. PubMed ID: 2776827 [TBL] [Abstract][Full Text] [Related]
59. Suppression of development of experimental autoimmune myasthenia gravis with isogeneic monoclonal anti-idiotopic antibody. Agius MA; Richman DP J Immunol; 1986 Oct; 137(7):2195-8. PubMed ID: 3489757 [TBL] [Abstract][Full Text] [Related]
60. Alpha-bungarotoxin blocking antibodies in neonatal myasthenia gravis: frequency and selectivity. Vernet-der Garabedian B; Eymard B; Bach JF; Morel E J Neuroimmunol; 1989 Jan; 21(1):41-7. PubMed ID: 2908881 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]